YOLFTbeta
MIRA Pharmaceuticals, Inc. Common Stock

MIRA Pharmaceuticals, Inc. Common Stock

MIRA · NASDAQ · Healthcare / Drug Manufacturers - General

0.6598USD+0.01 (+1.77%)

Price History

Full chart

Market Stats

Previous Close0.6483
Open0.638
Day Range0.6108 – 0.6643
52-Week Range0.60 – 2.45
Volume90.86K
Market Cap37.96M
P/E (TTM)0.00
Forward P/E0.00
EPS-1.22
Dividend Yield0.00%
Beta1.53
50-Day Avg0.7945
200-Day Avg1.06

About

MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a next-generation oral NMDA receptor modulator, that has completed a Phase 1 clinical trial. It also offers oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia; and SKNY-1, that is in preclinical stage for obesity and nicotine dependence. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is based in Miami, Florida.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - General
  • CEOMr. Erez Aminov
  • Employees0
  • Headquarters1200 Brickell Avenue, Miami, FL, United States, 33131, USA
  • Websitehttps://mirapharmaceuticals.com

Leadership

  • Mr. Erez AminovCEO & Chairman · b. 1978
  • Mr. Andriy Mushak CPAChief Financial Officer · b. 1983
  • Dr. Itzchak Angel Ph.D.Chief Scientific Advisor

Financials

Income Statement

Currency: USD2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue-00000
Cost of Revenue---8.53M--
Gross Profit----8.53M--
Operating Expense---0--
Operating Income-67.63K-2.15M-7.05M-8.53M-8.02M-10.49M
EBITDA-67.63K-2.15M-7.05M-8.53M-8.02M-10.44M
Net Income-67.99K-2.18M-7.06M-11.98M-7.85M-10.44M
R&D14.65K684.45K2.35M1.57M3.31M1.72M
Interest Expense36424.37K10.25K3.46M165.67K-

Balance Sheet

Currency: USD2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets22.37K3.36M858.07K4.93M2.92M11.09M
Total Liabilities90.36K1.09M1.45M558.10K723.35K702.07K
Total Equity-67.99K2.26M-596.23K4.37M2.20M10.39M
Cash3.49K2.81M350.98K4.60M2.83M6.35M
Total Debt90.00K293.06K491.23K5.06K--
Net Debt86.51K-2.52M140.25K-4.60M-2.83M-6.35M

Cash Flow

Currency: USD2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-67.99K-1.38M-5.60M-4.53M-5.56M-4.66M
Financing Cash Flow71.12K4.18M3.15M8.78M3.79M8.18M
Capital Expenditure300140
Free Cash Flow-67.99K-1.38M-5.60M-4.53M-5.56M-4.66M
FCF to OCF100.00%100.00%100.00%100.00%100.00%100.00%

Earnings

Report DateAug 30, 2023Nov 13, 2023Feb 28, 2024May 13, 2024Aug 13, 2024Nov 12, 2024Feb 26, 2025May 14, 2025Aug 14, 2025Nov 13, 2025Feb 25, 2026Jun 3, 2026Aug 12, 2026Nov 12, 2026
EPS Estimate0.00-0.08-0.23-0.10-0.11-0.15-0.13-0.14-0.13-0.08-0.08---
EPS Actual-0.10-0.26-0.37-0.12-0.11-0.14-0.17-0.11-0.09-0.07-0.14-0.03-0.03-
Surprise--225.00%-60.87%-20.00%0.00%6.67%-34.62%21.43%30.77%12.50%-78.38%---
Timing-After-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursPre-market----

Key Statistics & Ratios

Market Cap37.96M
Enterprise Value27.93M
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.00
Price / Book4.42
EPS-1.22
Book Value0.194
Revenue (TTM)0
Gross Profit (TTM)0
Profit Margin0.00%
Operating Margin0.00%
Return on Equity-217.12%
Return on Assets-129.55%
Shares Outstanding42.02M
Shares Float35.03M
Beta1.53
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Hold
Based on 1 analystsTarget 3.50
  • Hold
    1

Ownership Breakdown

Institutions
5.42%
Insiders
30.58%
Retail / Other
64.00%

Top Institutional Holders

  • Vanguard Capital Management, LLC
    693.91K1.65%
  • Cross Staff Investments Inc
    359.40K0.86%
  • Geode Capital Management, LLC
    290.89K0.69%
  • Vanguard Fiduciary Trust Co
    169.48K0.40%
  • BlackRock Inc
    112.35K0.27%
  • Northern Trust Corp
    67.70K0.16%
  • First American Bank/Carpentersville IL
    60.00K0.14%
  • Commonwealth Equity Services, LLC
    53.19K0.13%
  • State Street Corp
    49.10K0.12%
  • XTX Topco Ltd
    37.57K0.09%
  • International Assets Investment Management, LLC
    35.00K0.08%
  • Susquehanna International Group, LLP
    25.15K0.06%
  • Vanguard Global Advisers, LLC
    24.31K0.06%
  • Frec Markets Inc
    22.00K0.05%
  • Fifth Third Bancorp
    20.00K0.05%

Top Fund Holders

  • Vanguard MStar Total Stk Mkt Idx Invest
    394.08K0.94%
  • Fidelity Extended Market Index
    149.22K0.36%
  • iShares Micro-Cap ETF
    125.78K0.30%
  • Fidelity Series Total Market Index
    42.05K0.10%
  • Fidelity Total Market Index
    35.90K0.09%